Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Delphi Ventures
Delphi Ventures

Delphi Ventures

DeepTech NativeSan Mateo, United StatesActiveWebsiteLinkedIn
Stage FocusSeed, Series A, Series B+
GeographyUS
TypeVC
Last Activity2024
Industry Focus
Industries
BiotechMedTech
Technical BenchLimited
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Delphi Ventures is one of the longest-running healthcare-focused VCs in the US, founded in 1988 in San Mateo, California. Over more than two decades, the firm has committed over $1.1B across 8 funds and backed 170+ companies in biotechnology, medical devices, and health tech.

The track record includes 2 unicorns, 10 IPOs, and 33 acquisitions, with Tandem Diabetes Care (diabetes management devices...

Notable Investments
T
Tandem Diabetes Care
K
Karyopharm Therapeutics
R
Revance Therapeutics
P
PTC Therapeutics
A
Alder Biopharmaceuticals
R
Relypsa

Similar Funds

Abingworth

Abingworth

London, United Kingdom

DeepTech NativeBiotechMedTechSeedSeries A
Agent Capital

Agent Capital

Waltham, United States

DeepTech NativeBiotechMedTechNeurotechSeedSeries A
ARTIS Ventures

ARTIS Ventures

San Francisco, United States

DeepTech NativeBiotechAI InfrastructureMedTechSeedSeries A
Brandon Capital

Brandon Capital

Melbourne, Australia

DeepTech NativeBiotechMedTechSeedSeries A
Catalio Capital Management

Catalio Capital Management

New York, United States

DeepTech NativeBiotechMedTechSeedSeries A
Clal Biotechnology

Clal Biotechnology

Tel Aviv, Israel

DeepTech NativeBiotechMedTechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.